- Recommendation ID
- TA293/1
- Question
- NICE recommends that research should be carried out to directly compare eltrombopag with non-thrombopoietin receptor agonist treatments routinely used in UK clinical practice.
- Any explanatory notes
(if applicable) - None.
Source guidance details
- Comes from guidance
- Eltrombopag for treating chronic immune thrombocytopenia
- Number
- TA293
- Date issued
- July 2013
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 01/08/2013 |